Company Information

  

Address: 28 ESPLANADE  
City: SAINT HELIER 
State:  
Zip Code: JE2 3QA 
Telephone: 41274832286 

Description of Business

Primary SIC Code: 2835
(As filed with the SEC)  

We are a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. Our initial focus is on blood grouping and donor disease screening, which is commonly referred to as transfusion diagnostics. Blood grouping involves specific procedures performed at donor or patient testing laboratories to characterize blood, which includes antigen typing and antibody detection. Disease screening involves the screening of donor blood for unwanted pathogens using two different methods, a serological approach (testing for specific antigens or antibodies) and a molecular approach (testing for DNA or RNA). We have over 30 years of experience developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/2017-2.26NAN/E
09/2017-2.90NAN/E
06/2017-2.93NAN/E
03/2017-3.02NAN/E
12/2016-2.74NAN/E
09/2016-2.13NAN/E
06/2016-1.77NAN/E
03/2016-1.73NAN/E

Key Financial Ratios and Statistics

FYE: 03/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.45Total Liab/Total Assets1.22
Net Inc/Total Assets-0.77Total Liab/Inv Cap1.70
Net Inc/Inv Cap-1.08Total Liab/Comm Equity0.71
Pretax Inc/Net Sales-3.83Interest Coverage Ratio-7.59
Net Inc/Net Sales-3.83Curr Debt/Equity-0.06
Cash Flow/Net Sales-2.53LTD/Equity-3.36
SG&A/NetSales1.28Total Debt/Equity-3.41
Asset Utilization   Liquidity  
Net Receivables Turnover9.21Quick Ratio0.91
Inventory Turnover0.83Current Ratio1.37
Inventory Day Sales0.00Net Rec/Curr Assets0.06
Net Sales/Work Cap2.04Inv/Curr Assets0.34
Net Sales/PP&E0.35  

Income Statement (Millions)

  12/31/2017 9/30/2017 6/30/2017 3/31/2017
Total Revenues(Net Sales) 5.86 5.91 6.83 5.53
Cost of Goods Sold 2.33 2.79 2.83 2.39
Selling & Admin Exps 8.70 7.84 8.23 7.29
Operating Income -17.10 -18.06 -16.91 -17.74
Interest Exp 3.25 4.20 4.21 3.35
Pretax Income -20.31 -21.69 -20.24 -20.31
Other Income 0.03 0.56 0.88 0.78
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -20.31 -21.69 -20.24 -20.31

Balance Sheet (Millions)

Assets 12/31/2017 9/30/2017 6/30/2017 3/31/2017
Cash & Short Term Investments 33.83 19.82 40.67 20.81
Receivables - Total 2.02 2.46 2.80 2.56
Inventories - Total 16.52 15.22 14.81 13.64
Total Current Assets 56.02 41.44 62.96 40.63
Net Property, Plant & Equipment 75.89 74.89 70.06 63.53
Total Assets 137.78 122.22 138.85 109.97
Liabilities        
Accounts Payable 21.74 28.48 26.34 27.93
Debt in Current Liabilities 1.76 1.47 1.45 1.37
Total Current Liabilities 23.94 30.39 28.23 29.73
Long-Term Debt 85.58 84.03 82.30 80.88
Total Liabilities 133.96 138.60 134.38 134.06
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 253.93 217.88 217.89 172.62
Retained Earnings -255.54 -235.23 -213.54 -193.30
Treasury Stock NA NA NA NA
Total Stockholders' Equity 3.82 -16.38 4.47 -24.09
Total Liabilities and Stockholders' Equity 137.78 122.22 138.85 109.97

Cash Flow Summary (Millions)

Categories 12/31/2017 9/30/2017 6/30/2017 3/31/2017
Net Cash Provided by Operating Activities -20.33 -13.45 -19.15 -13.42
Net Cash Provided by Investing Activities -22.08 10.08 -17.01 9.02
Net Cash Provided by Financing Activities 39.64 -0.03 45.24 -4.78

Annual Summary Data (Millions)

Year Sales Net Income EPS
03/201314.37-4.71--
03/201419.76-10.16--
03/201518.41-59.06-0.40
03/201618.52-33.88-1.73
03/201722.23-85.07-3.02
Growth Rates11.52----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional12/31/176121,81147.85




Report Date : 2/12/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.